Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
LeMaitre VascularSTU:LHU +0.73%98 Pretax Margin % is 31.53% as of Jun. 2026, which is 50% above its 10-year median of 21.04. GuruFocus rates STU:LHU with a GF Score™ of 98/100 and a GF Value™ of €81.33 (Modestly Undervalued). Among 816 Medical Devices & Instruments companies, LeMaitre Vascular ranks better than 94.49% on this metric.
The historical rank and industry rank for LeMaitre Vascular's Pretax Margin % or its related term are showing as below:
STU:LHU'
s Pretax Margin % Range Over the Past 10 Years
Min: 17.01 Med: 21.04 Max: 32.29
Current: 32.29
STU:LHU's Pretax Margin % is ranked better than 94.49% of 816
companies
in the Medical Devices & Instruments industry
Industry Median: 2.31
vs STU:LHU: 32.29
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
LeMaitre Vascular Pretax Margin % Related Terms
LeMaitre Vascular Pretax Margin % Historical Data
* Premium members only.
The historical data trend for LeMaitre Vascular's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:LHU vs PLSE, XRAY, ATRC: Pretax Margin % Comparison
For the Medical Instruments & Supplies subindustry, LeMaitre Vascular's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LeMaitre Vascular Pretax Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, LeMaitre Vascular's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where LeMaitre Vascular's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LeMaitre Vascular (STU:LHU) has a Pretax Margin % of 31.53% as of Jun. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on LeMaitre Vascular and its competitors. This is 50% above median its historical median of 21.04. Over the past decade, LeMaitre Vascular's Pretax Margin % has ranged from 17.01 to 32.29. According to the industry distribution chart, LeMaitre Vascular ranks #45 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 5.5%.
Is LeMaitre Vascular's Pretax Margin % too high?
LeMaitre Vascular's current Pretax Margin % of 31.53% is 50% above median its 10-year median of 21.04. Over the past 10 years, this metric has ranged from a low of 17.01 to a high of 32.29. The Medical Devices & Instruments industry median Pretax Margin % is 2.31. LeMaitre Vascular's value of 31.53% is 1264.9% above this industry median. Based on the distribution chart, LeMaitre Vascular ranks #45 out of 816 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, LeMaitre Vascular has a GF Score™ of 98/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does LeMaitre Vascular's Pretax Margin % compare to PLSE and XRAY?
According to the Medical Devices & Instruments industry distribution chart, LeMaitre Vascular ranks #45 out of 816 companies for Pretax Margin %. This places LeMaitre Vascular in the top 6% of its industry — outperforming the majority of peers. The industry median Pretax Margin % is 2.31. LeMaitre Vascular's value of 31.53% is 1264.9% above this benchmark. Historically, LeMaitre Vascular's own Pretax Margin % has ranged from 17.01 to 32.29 over the past decade. While the company's 10-year median is 21.04 vs. the industry median of 2.31, LeMaitre Vascular has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Medical Devices & Instruments company?
The median Pretax Margin % among Medical Devices & Instruments companies is 2.31, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. LeMaitre Vascular's current Pretax Margin % of 31.53% is 1264.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on LeMaitre Vascular and its competitors. For the Medical Devices & Instruments industry, the median Pretax Margin % is 2.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LeMaitre Vascular's current Pretax Margin % is 31.53%, which is 50% above median its own 10-year median of 21.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LeMaitre Vascular stock overvalued right now?
Based on GuruFocus' analysis, LeMaitre Vascular (STU:LHU) is currently considered Modestly Undervalued. The stock's GF Value™ is €81.33, compared to a current price of €69.00 — trading 15.2% below its estimated fair value. The current Pretax Margin % is 31.53%, which is 50% above median its 10-year median of 21.04 and 1264.9% above the Medical Devices & Instruments industry median of 2.31. LeMaitre Vascular's overall GF Score™ is 98/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For LeMaitre Vascular (STU:LHU), the current Pretax Margin % is 31.53% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is LeMaitre Vascular (STU:LHU) Overvalued in 2026?
Based on GuruFocus' analysis, LeMaitre Vascular stock appears to be undervalued.
The current stock price of €69.00 is trading 15.2% below its estimated GF Value™ of €81.33.
GuruFocus considers LeMaitre Vascular to be Modestly Undervalued.
Key valuation signals for STU:LHU:
Pretax Margin %: 31.53% (50% above median its 10-year median of 21.04)
GF Value™: €81.33 vs. price of €69.00 (15.2% below fair value)
Industry Position: 1264.9% above the Medical Devices & Instruments median (#45 of 816)
No single metric tells the full story. See the STU:LHU stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.
98GF Score
Get the complete analysis for STU:LHU
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:LHU has been successfully added to your 
